A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00073489. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pilot Trial of OSI-461 in Patients With Chronic Lymphocytic Leukemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objectives of this study are to evaluate the safety and efficacy of OSI-461 in CLL patients.
Study identification
- NCT ID
- NCT00073489
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 23 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2001 (Type not available)
- Primary completion
- Not listed
- Completion
- Dec 2003 (Actual)
- Last update posted
- Oct 17, 2011
2001 – 2003
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Hematology & Oncology Associates | Phoenix | Arizona | 85012 | — |
| Rocky Mountain Cancer Centers | Aurora | Colorado | 80012 | — |
| Florida Oncology Associates | Jacksonville | Florida | 32207 | — |
| Ocala Oncology Center | Ocala | Florida | 34474 | — |
| Iowa Oncology Associates | Cedar Rapids | Iowa | 52403 | — |
| Oncology/Hematology Associates of Kansas City | Kansas City | Missouri | 64111 | — |
| Piedmont Hem Onc Assoc, P.A. | Winston-Salem | North Carolina | 27103 | — |
| Dayton Oncology/Hematology Consultants | Dayton | Ohio | 45439 | — |
| Willamette Valley Cancer Center | Eugene | Oregon | 97401 | — |
| Cancer Centers of the Carolinas | Greenville | South Carolina | 29615 | — |
| Southwest Regional Cancer Center | Austin | Texas | 78705 | — |
| Hematology Oncology Associates of South Texas | San Antonio | Texas | 78229 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Oncology & Hematology Associates of Southwest Virginia | Roanoke | Virginia | 24101 | — |
| Cancer Care Northwest | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00073489, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 17, 2011 · Synced Nov 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.